Advertisement

Topics

STAT Plus: Will a boom in genetic testing of tumors be a boon for Soon-Shiong?

04:30 EST 13 Nov 2017 | STAT

Dr. Patrick Soon-Shiong hopes to expand sales of his struggling cancer diagnostic by testing for MSI status, but it's not clear his test does anything new.

Original Article: STAT Plus: Will a boom in genetic testing of tumors be a boon for Soon-Shiong?

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Will a boom in genetic testing of tumors be a boon for Soon-Shiong?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...